Hi everybody, I am a new user of this forum. I am student in Biotechnology field. I hope I'll get help from this forum.
-
-
Hello and intro
I am working with my colleague on NGS analyses primarily dealing with clinical and environmental prokaryotes. We use the MiSeq and have been experiencing quite the learning curve.
Our location is in the state of Nevada (and yes it is Las Vegas). I look forward to learning much from all and perhaps develop new collaborations.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment